Coexpression cluster:C336: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(5 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 11:20, 17 September 2013
Full id: C336_left_heart_skeletal_breast_lung_mature_adipose
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
3.08914508387101e-06 | 0.00195542883809035 | 2 | 8 | Fatty acid elongation in mitochondria (KEGG):00062 |
0.000103669183166052 | 0.0164056482360278 | 2 | 44 | Fatty acid metabolism (KEGG):00071 |
0.000103669183166052 | 0.0164056482360278 | 2 | 44 | Valine, leucine and isoleucine degradation (KEGG):00280 |
0.000318679660048518 | 0.0390577663331827 | 2 | 77 | Cardiac muscle contraction (KEGG):04260 |
0.000370215794627324 | 0.0390577663331827 | 2 | 83 | Hypertrophic cardiomyopathy (HCM) (KEGG):05410 |
0.000435138292981747 | 0.0393489342082066 | 2 | 90 | Dilated cardiomyopathy (KEGG):05414 |
6.15932363774147e-05 | 0.0164056482360278 | 2 | 34 | Fatty Acid Beta Oxidation (Wikipathways):WP143 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0003988 | acetyl-CoA C-acyltransferase activity | 6.92129505418527e-05 |
GO:0004300 | enoyl-CoA hydratase activity | 6.92129505418527e-05 |
GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity | 6.92129505418527e-05 |
GO:0016408 | C-acyltransferase activity | 0.000228214532956531 |
GO:0006635 | fatty acid beta-oxidation | 0.00052500760191928 |
GO:0006631 | fatty acid metabolic process | 0.000530362812756355 |
GO:0019395 | fatty acid oxidation | 0.000800337080983666 |
GO:0032787 | monocarboxylic acid metabolic process | 0.00118596621311143 |
GO:0008016 | regulation of heart contraction | 0.00118596621311143 |
GO:0008307 | structural constituent of muscle | 0.00118596621311143 |
GO:0003015 | heart process | 0.00119419938607684 |
GO:0060047 | heart contraction | 0.00119419938607684 |
GO:0030017 | sarcomere | 0.00119419938607684 |
GO:0030016 | myofibril | 0.00135373569175321 |
GO:0044449 | contractile fiber part | 0.00162135059197157 |
GO:0043292 | contractile fiber | 0.00173032124461943 |
GO:0003779 | actin binding | 0.00220390170700477 |
GO:0016836 | hydro-lyase activity | 0.00280062572538729 |
GO:0016508 | long-chain-enoyl-CoA hydratase activity | 0.00280062572538729 |
GO:0016507 | fatty acid beta-oxidation multienzyme complex | 0.00280062572538729 |
GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity | 0.00280062572538729 |
GO:0016835 | carbon-oxygen lyase activity | 0.00313629135527366 |
GO:0008092 | cytoskeletal protein binding | 0.00416575764242442 |
GO:0005516 | calmodulin binding | 0.00509004928055831 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 0.00509004928055831 |
GO:0008015 | blood circulation | 0.00509004928055831 |
GO:0003013 | circulatory system process | 0.00509004928055831 |
GO:0006200 | ATP catabolic process | 0.00509004928055831 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 0.00509004928055831 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 0.00509004928055831 |
GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity | 0.00509004928055831 |
GO:0003985 | acetyl-CoA C-acetyltransferase activity | 0.00509004928055831 |
GO:0009203 | ribonucleoside triphosphate catabolic process | 0.00509004928055831 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 0.00509004928055831 |
GO:0003012 | muscle system process | 0.00509004928055831 |
GO:0006936 | muscle contraction | 0.00509004928055831 |
GO:0044255 | cellular lipid metabolic process | 0.00523876299108885 |
GO:0019752 | carboxylic acid metabolic process | 0.00534476070800211 |
GO:0006082 | organic acid metabolic process | 0.00534476070800211 |
GO:0009154 | purine ribonucleotide catabolic process | 0.00534476070800211 |
GO:0009143 | nucleoside triphosphate catabolic process | 0.00534476070800211 |
GO:0006195 | purine nucleotide catabolic process | 0.00534476070800211 |
GO:0005862 | muscle thin filament tropomyosin | 0.00534476070800211 |
GO:0030898 | actin-dependent ATPase activity | 0.00534476070800211 |
GO:0016453 | C-acetyltransferase activity | 0.00625377080234083 |
GO:0033275 | actin-myosin filament sliding | 0.00625377080234083 |
GO:0030049 | muscle filament sliding | 0.00625377080234083 |
GO:0009261 | ribonucleotide catabolic process | 0.00707946691661464 |
GO:0002027 | regulation of heart rate | 0.00707946691661464 |
GO:0006629 | lipid metabolic process | 0.00707946691661464 |
GO:0055010 | ventricular cardiac muscle morphogenesis | 0.00777643195140338 |
GO:0007512 | adult heart development | 0.00777643195140338 |
GO:0008415 | acyltransferase activity | 0.00777643195140338 |
GO:0016747 | transferase activity, transferring groups other than amino-acyl groups | 0.00777643195140338 |
GO:0005515 | protein binding | 0.00788231127580342 |
GO:0048644 | muscle morphogenesis | 0.00824767501883972 |
GO:0055008 | cardiac muscle morphogensis | 0.00824767501883972 |
GO:0051239 | regulation of multicellular organismal process | 0.0087020181146306 |
GO:0016829 | lyase activity | 0.0087020181146306 |
GO:0015629 | actin cytoskeleton | 0.00952041531412415 |
GO:0016746 | transferase activity, transferring acyl groups | 0.00952041531412415 |
GO:0005865 | striated muscle thin filament | 0.01028524455451 |
GO:0005743 | mitochondrial inner membrane | 0.01028524455451 |
GO:0019866 | organelle inner membrane | 0.0112964660841367 |
GO:0045104 | intermediate filament cytoskeleton organization and biogenesis | 0.012648071284402 |
GO:0045103 | intermediate filament-based process | 0.0131454347830111 |
GO:0000146 | microfilament motor activity | 0.0131454347830111 |
GO:0030048 | actin filament-based movement | 0.0134192831021231 |
GO:0032982 | myosin filament | 0.0134192831021231 |
GO:0005863 | striated muscle thick filament | 0.0134192831021231 |
GO:0031966 | mitochondrial membrane | 0.0153170358144426 |
GO:0005856 | cytoskeleton | 0.0155226771801919 |
GO:0000062 | acyl-CoA binding | 0.0160771851772659 |
GO:0005740 | mitochondrial envelope | 0.016423777393706 |
GO:0005859 | muscle myosin complex | 0.0192918421568587 |
GO:0009166 | nucleotide catabolic process | 0.0192918421568587 |
GO:0016460 | myosin II complex | 0.0198006200548218 |
GO:0000302 | response to reactive oxygen species | 0.0202961757118159 |
GO:0005504 | fatty acid binding | 0.0229972128803536 |
GO:0006941 | striated muscle contraction | 0.0269794578053047 |
GO:0044429 | mitochondrial part | 0.0269794578053047 |
GO:0042221 | response to chemical stimulus | 0.0269794578053047 |
GO:0006937 | regulation of muscle contraction | 0.0275117531679227 |
GO:0031967 | organelle envelope | 0.0290746276768742 |
GO:0031975 | envelope | 0.0290746276768742 |
GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity | 0.0306153492651917 |
GO:0004112 | cyclic-nucleotide phosphodiesterase activity | 0.0316010541811552 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.0336575397112977 |
GO:0044446 | intracellular organelle part | 0.0404207849669413 |
GO:0044422 | organelle part | 0.0404207849669413 |
GO:0042493 | response to drug | 0.0404207849669413 |
GO:0051287 | NAD binding | 0.0456447248263079 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
heart disease | 6.23e-17 | 2 |
vascular disease | 2.82e-09 | 1 |
ischemia | 2.82e-09 | 1 |
extrinsic cardiomyopathy | 2.82e-09 | 1 |
myocardial ischemia | 2.82e-09 | 1 |
myocardial infarction | 2.82e-09 | 1 |
cardiovascular system disease | 6.48e-09 | 4 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.0478156 |
MA0004.1 | 0.262334 |
MA0006.1 | 0.100229 |
MA0007.1 | 0.515741 |
MA0009.1 | 0.375925 |
MA0014.1 | 0.00846735 |
MA0017.1 | 0.904952 |
MA0019.1 | 0.151679 |
MA0024.1 | 0.294311 |
MA0025.1 | 0.487069 |
MA0027.1 | 1.90579 |
MA0028.1 | 0.273688 |
MA0029.1 | 0.308904 |
MA0030.1 | 0.300221 |
MA0031.1 | 0.703934 |
MA0038.1 | 0.126016 |
MA0040.1 | 0.313366 |
MA0041.1 | 0.0839596 |
MA0042.1 | 0.070122 |
MA0043.1 | 0.376179 |
MA0046.1 | 0.367181 |
MA0048.1 | 0.164128 |
MA0050.1 | 0.528958 |
MA0051.1 | 0.78189 |
MA0052.1 | 0.848544 |
MA0055.1 | 0.0106179 |
MA0056.1 | 0 |
MA0057.1 | 0.0792479 |
MA0058.1 | 0.0404315 |
MA0059.1 | 0.156159 |
MA0060.1 | 0.088709 |
MA0061.1 | 0.144596 |
MA0063.1 | 0 |
MA0066.1 | 0.126249 |
MA0067.1 | 0.649823 |
MA0068.1 | 0.302496 |
MA0069.1 | 0.364099 |
MA0070.1 | 0.355189 |
MA0071.1 | 0.105665 |
MA0072.1 | 0.351626 |
MA0073.1 | 0.0336902 |
MA0074.1 | 0.123313 |
MA0076.1 | 0.173334 |
MA0077.1 | 0.345539 |
MA0078.1 | 0.537126 |
MA0081.1 | 0.156318 |
MA0083.1 | 0.381987 |
MA0084.1 | 0.823032 |
MA0087.1 | 0.349692 |
MA0088.1 | 0.162232 |
MA0089.1 | 0 |
MA0090.1 | 0.0504181 |
MA0091.1 | 4.67545 |
MA0092.1 | 0.221134 |
MA0093.1 | 0.102646 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.133688 |
MA0101.1 | 0.105302 |
MA0103.1 | 0.440826 |
MA0105.1 | 0.0266755 |
MA0106.1 | 0.14939 |
MA0107.1 | 0.147251 |
MA0108.2 | 0.69888 |
MA0109.1 | 0 |
MA0111.1 | 0.055257 |
MA0113.1 | 0.480586 |
MA0114.1 | 0.750855 |
MA0115.1 | 0.581155 |
MA0116.1 | 0.306176 |
MA0117.1 | 0.406527 |
MA0119.1 | 0.0352635 |
MA0122.1 | 0.42795 |
MA0124.1 | 0.544476 |
MA0125.1 | 0.471774 |
MA0130.1 | 0 |
MA0131.1 | 0.565286 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.400588 |
MA0136.1 | 0.129893 |
MA0139.1 | 0.0163043 |
MA0140.1 | 0.104326 |
MA0141.1 | 0.637869 |
MA0142.1 | 0.230443 |
MA0143.1 | 2.13898 |
MA0144.1 | 0.443601 |
MA0145.1 | 0.12156 |
MA0146.1 | 0.000772138 |
MA0147.1 | 0.058287 |
MA0148.1 | 1.52127 |
MA0149.1 | 0.0995233 |
MA0062.2 | 0.0589056 |
MA0035.2 | 0.339371 |
MA0039.2 | 0.0486388 |
MA0138.2 | 0.183007 |
MA0002.2 | 0.0772163 |
MA0137.2 | 0.526676 |
MA0104.2 | 0.0879339 |
MA0047.2 | 0.862783 |
MA0112.2 | 0.399857 |
MA0065.2 | 0.211429 |
MA0150.1 | 0.0483839 |
MA0151.1 | 0 |
MA0152.1 | 0.70943 |
MA0153.1 | 1.15826 |
MA0154.1 | 0.633854 |
MA0155.1 | 0.247958 |
MA0156.1 | 0.120803 |
MA0157.1 | 0.211768 |
MA0158.1 | 0 |
MA0159.1 | 1.13838 |
MA0160.1 | 0.0939956 |
MA0161.1 | 0 |
MA0162.1 | 0.0836811 |
MA0163.1 | 0.0612281 |
MA0164.1 | 0.499229 |
MA0080.2 | 0.102716 |
MA0018.2 | 0.45833 |
MA0099.2 | 0.107829 |
MA0079.2 | 0.000750601 |
MA0102.2 | 0.858102 |
MA0258.1 | 0.643532 |
MA0259.1 | 0.0634142 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
ESRRA#2101 | 2 | 28.4611949491839 | 0.00228776074824822 | 0.0129839933043308 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.